Default, Transition, and Recovery: Global Corporate Default Update (July 28 - Aug. 3, 2011) Aug 11

  • ID: 1857625
  • August 2011
  • Region: Global
  • Standard & Poors
1 of 2

The 2011 global corporate default tally remains at 21 after no corporate issuers defaulted this week. Of the total defaulters this year, 13 were based in the U.S., three were based in New Zealand, two were based in Canada, and one each was based in the Czech Republic, France, and Russia. By comparison, 54 global corporate issuers had defaulted by this time in 2010. Of these defaulters, 38 were U.S.-based issuers, two were European issuers, seven were from the emerging markets, and another seven were in the other developed region (Australia, Canada, Japan, and New Zealand). Eight of this year's defaults were due to missed interest or principal payments and seven were due to distressed exchanges--both among the top reasons...

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Commentary
Criteria articles describe the thought process and methodology Standard & Poor's analysts use in determining ratings. These commentary pieces discuss both the quantitative (economic and financial) and qualitative (business analysis and caliber of management) aspects of the analysis, as well as legal issues.

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.